Haploidentical Transplant for People With Chronic Granulomatous Disease Using Post Transplant Cyclophosphamide
Clinical trial NCT02282904 · TERMINATED
Trial details
- NCT number
- NCT02282904
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-10-23
- Primary completion
- 2019-04-10
- Enrollment
- 7
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.